1990
DOI: 10.1016/0012-1606(90)90397-2
|View full text |Cite
|
Sign up to set email alerts
|

Differential expression of fetomodulin and tissue plasminogen activator to characterize parietal endoderm differentiation of F9 embryonal carcinoma cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
7
1

Year Published

1992
1992
2007
2007

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(8 citation statements)
references
References 14 publications
0
7
1
Order By: Relevance
“…The synergistic action of these two hormones requires a time-dependent change in F9 cells induced by RA. These data are somewhat at variance with those of other investigators who employed receptor activity assays to show that RACT, but not RA alone, induced TM expression (7). We suspect that the relative insensitivity of the biologic activity measurements may have been responsible for the lack of detection of RA-induced TM expression.…”
contrasting
confidence: 56%
See 1 more Smart Citation
“…The synergistic action of these two hormones requires a time-dependent change in F9 cells induced by RA. These data are somewhat at variance with those of other investigators who employed receptor activity assays to show that RACT, but not RA alone, induced TM expression (7). We suspect that the relative insensitivity of the biologic activity measurements may have been responsible for the lack of detection of RA-induced TM expression.…”
contrasting
confidence: 56%
“…F9 mouse embryonal carcinoma cells provide a suitable in vitro model to study the developmental regulation ofTM gene expression (7). F9 cells can be either maintained in vitro as undifferentiated stem cells or hormonally induced to differentiate into a restricted number of cell types found within the developing mouse embryo: retinoic acid (RA) converts F9 stem cells to a phenotype that is functionally similar to primitive endoderm (8,9), whereas cultivation of the RAtreated cells in the presence of agents that increase intracellular cAMP causes differentiation to a phenotype resembling extraembryonic parietal endoderm (10).…”
mentioning
confidence: 99%
“…This distinction is illustrated in the study by Yoshida et al (43) who showed that iatrogenic toxic renal failure could be distinguished from graft rejection in renal transplantation patients treated with cyclosporine. In EC, TM is mainly up-regulated by cAMP and retinoic acid and down-regulated by endo toxin and inflammatory cytokines (Table 3A) (44)(45)(46)(47)(48)(49)(50)(51)(52)(53)(54)(55). This down-regulation can be poten tiated by interferon g (56) but is antagonized by retinoic acid, IL-4 and IL-13 (57)(58)(59).…”
Section: Tm Metabolism and Regulationmentioning
confidence: 99%
“…The alternative differentiation pathway to parietal endoderm is induced by treatment of F9 cells with RA and dibutyryl cyclic AMP (dbcAMP) (Strickland et al, 1980). Under these conditions, refractile, highly migratory SSEA-1negative cells are generated (Stricldand et al, 1980;Marotti et al, 1982;Imada et al, 1990) that express elevated levels of collagen IV, laminin, and tissue plasminogen activator (tPA). As in the case of VE, the behavior and biochemical properties of F9-derived PE mimic those properties of PE in the mouse embryo, in which ceils detach from the periphery of the stationary endoderm layer that covers the inner cell mass, migrate along the inner surface of the trophoblast and egg cylinder, and synthesize the proteins characteristic of F9-derived PE.…”
mentioning
confidence: 99%